Oak Longevity vs Sprout Health: Price, Speed, and Value
Comparing Oak Longevity vs Sprout Health quickly: Oak Longevity is built around low flat prices and no subscriptions, while Sprout Health emphasizes fast approval and a $50 first-month discount. Early verdict: choose Oak for lowest ongoing price sensitivity; choose Sprout for fastest onboarding and an initial discount.
See Oak Longevity pricing and plans
Direct comparison summary: what sets them apart
Oak Longevity offers compounded semaglutide starting at $133/month and tirzepatide starting at $199/month with one flat price for all dosages, no subscriptions, and free health coaching and shipping. Sprout Health offers $50 off the first month, bringing the initial cost to $199, with ongoing pricing reported at $249/month and a focus on lightning-quick approval and outcome framing of 10–26% body weight reduction over 12 months. Both operate via online clinician review and may offer compounded medications that are not FDA-approved finished products.
Check Sprout Health special offer
Price and billing: flat low price versus discount then higher ongoing cost
Price is the clearest contrast in Oak Longevity vs Sprout Health. Oak advertises semaglutide from $133/month and tirzepatide from $199/month, one flat price for all dosages, billed monthly on a non-recurring basis with no subscription required. Sprout Health markets $50 off the first month, bringing that first month to $199, with standard ongoing pricing at $249/month per captured materials. Oak highlights no membership fees and no hidden costs; Sprout highlights a meaningful introductory discount but a higher ongoing rate.
Onboarding speed and clinician review
Oak conducts an online health questionnaire with a licensed clinician reviewing information asynchronously; Oak notes no video call is required and same-day approval is available for qualifying patients. Sprout Health emphasizes a lightning-quick approval process and fast, hassle-free onboarding. Both require a licensed clinician to determine if treatment is medically appropriate.
Product type and regulatory notes
Both providers offer compounded GLP-1 medications. Oak explicitly states its compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness or quality. Sprout’s materials also note that compounded medications, when offered, are not FDA-approved and branded and compounded products are not interchangeable. These regulatory qualifiers are present for both.
Features, extras, and limitations
Oak includes free health coaching and free shipping with tracking as part of its offering and emphasizes no subscriptions and no auto-charge; three-month prescriptions are billed upfront and Oak states no refunds are available after physician approval and once medication has shipped. Oak also notes patients with BMI below 20 do not qualify for GLP-1 treatment and not for patients under 18, pregnant, or nursing. Sprout highlights outcome framing of 10–26% body weight reduction over 12 months based on GLP-1 literature and a no-frills, fast-entry experience; Sprout does not publish an outcome guarantee in the captured content.
Distinctive differences at a glance
| Criteria | Oak Longevity | Sprout Health |
|---|---|---|
| Starting price | Semaglutide from $133/mo; tirzepatide from $199/mo | $50 off first month to $199; $249/mo ongoing |
| Billing model | Non-recurring monthly billing, no subscription | Direct-pay; first-month discount then standard rate |
| Approval speed | Asynchronous clinician review; same-day approval available | Lightning-quick approval emphasized |
| Added services | Free health coaching and free shipping with tracking | No-frills fast entry; discount first month |
| Regulatory note | Compounded medications not FDA-approved finished products | Compounded medications not FDA-approved; branded and compounded not interchangeable |
Start with Sprout Health offer
Clinical and eligibility limits
Oak specifies patients with BMI below 20 do not qualify for GLP-1 treatment and that treatment is available only when a licensed clinician determines it is medically appropriate. Sprout also states treatment is available only when a licensed clinician determines it is medically appropriate. Both providers note compounded medications are not FDA-approved finished products; Oak repeats that these are compounded versions of active ingredients.
Conclusion: Oak Longevity vs Sprout Health and who to choose
In summary of Oak Longevity vs Sprout Health: Oak focuses on the lowest ongoing cost with semaglutide from $133/month and tirzepatide from $199/month, no subscriptions, and free coaching and shipping. Sprout focuses on fast approval and a first-month discount that brings month one to $199 but reports a $249/month ongoing rate.
Choose Oak Longevity if you are cost-conscious and want low flat pricing, no subscription, free health coaching, and free shipping, and you accept compounded medication limitations. Choose Sprout Health if you prioritize the fastest onboarding and value an initial $50 first-month discount and clear outcome framing about expected weight change over 12 months.